Blackstone Inc. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Blackstone Inc. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$47,731,474
-2.1%
20,485,6110.0%0.20%
-4.3%
Q2 2023$48,755,754
+29.3%
20,485,6110.0%0.21%
+35.7%
Q1 2023$37,693,524
-3.2%
20,485,6110.0%0.15%
+4.1%
Q4 2022$38,922,661
+101026.7%
20,485,611
+13.9%
0.15%
+4.2%
Q3 2022$38,489
-99.9%
17,985,6110.0%0.14%
-16.0%
Q2 2022$50,899,000
-32.1%
17,985,6110.0%0.17%
-11.1%
Q1 2022$75,000,000
-19.7%
17,985,6110.0%0.19%
-18.8%
Q4 2021$93,345,00017,985,6110.23%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders